2012
DOI: 10.1007/s10620-012-2228-y
|View full text |Cite
|
Sign up to set email alerts
|

Bin1: A New Player in IBD Barrier Dysfunction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…The attenuation of Bin1 reduced the severity in an experimental colitis model through the enhancement of epithelial barrier function . Moreover, the Bin1 antibody has been reported to display the alteration influence on tight junction, as well as the improvement of barrier function . The decreased expression of Bin1 in the PEP treatment group suggested a supporting impact of PEP on gut mucosal barrier function and integrity.…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…The attenuation of Bin1 reduced the severity in an experimental colitis model through the enhancement of epithelial barrier function . Moreover, the Bin1 antibody has been reported to display the alteration influence on tight junction, as well as the improvement of barrier function . The decreased expression of Bin1 in the PEP treatment group suggested a supporting impact of PEP on gut mucosal barrier function and integrity.…”
Section: Discussionmentioning
confidence: 95%
“…[56] Moreover, the Bin1 antibody has been reported to display the alteration influence on tight junction, as well as the improvement of barrier function. [57] The decreased expression of Bin1 in the PEP treatment group suggested a supporting impact of PEP on gut mucosal barrier function and integrity.…”
Section: Proteins Associated With the Host Immune Responsementioning
confidence: 96%
“…Bridging Integrator (BinI) transgenic mice exhibit modified intestinal permeability through the action on intestinal tight junctional maintenance [ 77 ]. Interestingly, ablating BIN1 does not appear to modify histological appearance of tissues alone, but does increase functional resistance of mice to action by dextran sodium sulfateinduced colitis: treated mice exhibited increased survival, and decreased clinical manifestations of IBD such as hematochezia, diarrhea, and weight loss that was specifically associated with immune dysfunction, and not with general disruption of tight junction permeability as documented by treatment of control mice with phorbol ester or sodium caprate [ 77 ].…”
Section: Transgenic Animal Models Of Crohn's Diseasementioning
confidence: 99%
“… References to each model are as follows: 1 [ 51 52 53 ]. 2 http://jaxmice.jax.org/strain/003451.html; 3 [ 54 ]; 4 [ 56 ]; 5 http:/jaxmice.jax.org/strain/003008.html; 6 [ 61 62 87 ]; 7 [ 50 65 ]; 8 [ 68 ]; 9 [ 33 ]; 10 [ 26 45 88 ]; 11 [ 26 ]; 12 [ 54 ]; 13 [ 71 ]; 14 [ 33 68 ]; 15 [ 68 ], http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6980; 16 [ 68 72 ], http://jaxmice.jax.org/strain/025630.html; 17 [ 77 ]; 18 [ 33 ]; 19 [ 7 45 78 ]; 20 [ 8 45 59 ], http://jaxmice.jax.org/list/ra1655.html, http://jaxmice.jax.org/jaxnotes/502/502a.html; 21 [ 8 59 ] …”
Section: Tablementioning
confidence: 99%